Market Dynamics:
Advancements in targeted therapy is one of the major drivers fueling growth of the cancer therapy market. Development of novel targeted drugs targeting specific mutations in cancer cells has improved efficacy and reduced side effects associated with conventional chemotherapy. For instance, development of Herceptin by Roche targeted HER2 protein in breast cancer cells. This has significantly improved treatment outcomes for HER2-positive breast cancer. Additionally, availability of comprehensive genomic profiling helps in identifying molecular changes in tumors and matches patients with suitable targeted therapies.

Key Takeaways

The Global Cancer Therapy Market Size is expected to witness high growth. The market size is projected to reach US$ 301113.55 Mn by 2030 from US$ 201103.55 Mn in 2023, expanding at a CAGR of 8.4% during the forecast period.

For More Insights, Read: https://newsinsights123.blogspot.com/2023/12/cancer-therapy-market-poised-for-rapid.html